Army scientists have demonstrated that a “decoy” receptor developed by University of Illinois researchers has potent neutralizing activity against SARS-CoV-2–activity that is on par with the best neutralizing antibodies identified to date. Furthermore, they found that the decoy receptor not only neutralizes SARS-CoV-2, but also acts to neutralize SARS-CoV-1, a closely related virus that uses the same cellular receptor. Results appear in the Aug. 4 online edition of Science.
- Ecological power storage battery made of vanillin
- The most sensitive optical receivers yet for space communications
- The development of climate security discourse in Japan
- Foreign election interference focuses on cultivating distrust, reducing consensus
- COVID-19 infects majority of bad dreams — study